期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
与噻氯匹定相比,冠状动脉支架置入术后服用氯吡格雷使患者的远期支架内血栓形成发生率及死亡率升高
1
作者 wolak a. amit G. +2 位作者 Cafri C. D. Zahger 杜媛 《世界核心医学期刊文摘(心脏病学分册)》 2006年第1期58-59,共2页
Background: Clopidogrel has largely replaced ticlopidine following coronary stent implantation. Recently, concern has been raised regarding the possibility of excess long term mortality in patients given clopidogrel r... Background: Clopidogrel has largely replaced ticlopidine following coronary stent implantation. Recently, concern has been raised regarding the possibility of excess long term mortality in patients given clopidogrel rather than ticlopidine following coronary stenting. Methods: We studied 1519 consecutive patients who underwent 2020 stent implantations and were discharged on dual antiplatelet regimens of either aspirin and ticlopidine or aspirin and clopidogrel given for up to 4 weeks. Thrombotic stent occlusion(TSO) was defined as ST elevation myocardial infarction in the stented artery territory associated with angiographic demonstration of complete stent occlusion. Mortality follow up was obtained for all patients by linkage to the Population Register. Follow up duration was 12 months. Results: TSO occurred in 37 stents at a median of 29 days post procedure. Of these cases, six occurred in the ticlopidine group(0.7%) and 31 in the clopidogrel group(2.8%)(p< 0.01). The median time to TSO was 34 days and 28 days in ticlopidine and clopidogrel treated patients, respectively(p< 0.01). After controlling for multiple demographic, clinical and angiographic variables clopidogrel(vs. ticlopidine) treatment remained the sole predictor of TSO(OR: 5.4,95%CI=1.2-24.1, p=0.028). Of even more concern, clopidogrel treatment was associated with an increased risk of 1 year mortality(OR: 1.8, 95%CI=1.2-2.8). Conclusions: Long term follow up after stent implantation in patients receiving the traditional 2-4 weeks course of dual antiplatelet therapy reveals increased rates of TSO and mortality in patients given clopidogrel as opposed to ticlopidine. Whether longer treatment with clopidogrel will change these observations deserves further study. 展开更多
关键词 支架内血栓形成 冠状动脉支架 噻氯匹定 氯吡格雷 置入术后 死亡率 患者 升高 发生率 服用
下载PDF
以色列士兵足癣的患病率和危险因素
2
作者 Cohen a.D. wolak a. +1 位作者 alkanM. 罗素菊 《世界核心医学期刊文摘(皮肤病学分册)》 2006年第3期57-58,共2页
Background: Tinea pedis is a common infection in soldiers. However, prevalence and risk factors for tinea pedis in soldiers were investigated in only a few studies. Objectives: To investigate the prevalence and risk f... Background: Tinea pedis is a common infection in soldiers. However, prevalence and risk factors for tinea pedis in soldiers were investigated in only a few studies. Objectives: To investigate the prevalence and risk factors for tinea pedis in Israeli soldiers. Methods: A cross-sectional study including interviews, clinical skin examination and mycological tests was performed in Israeli soldiers. The presence of tinea pedis was assessed using the Athlete s Foot Severity Index (AFSI), a scoring system that was developed in order to evaluate the presence and severity of tinea pedis. In soldiers with clinical evidence of tinea pedis (AFSI > 1), scrapings were taken for direct microscopic examination (20% KOH preparation) and fungal culture. Statistical analyses were performed using chi-square or Fisher s exact test for dichotomous variables (as needed), or t-tests for continuous variables. Logistic regression was used for multivariate analyses of dichotomous variables. Results: Two hundred and twenty-three soldiers were included in the study: 205 men (91.9% ) and 18 women (8.1% ). Mean age was 19.6 years (SD 1.0 year). Clinical point prevalence was 60.1% . Mycological point prevalence was 27.3% . Further analyses were performed using the clinical point prevalence. Univariate analyses demonstrated that the prevalence of tinea pedis varied with the setting of military training (basic training: 70.3% , advanced infantry training: 81.5% , armor commander training: 56.4% and armor officer training: 34.8% ) and was associated with male gender, frequency of sock changes and the length of military service. A multivariate analysis demonstrated that tinea pedis was associated with the setting of the military training (OR 1.6, 95% Cl 1.2- 2.1) and male gender (OR 4.3, 95% Cl 1.4- 13.8); however, there was no association with hygiene measures (e.g. frequency of changing socks or sleeping with socks) or the length of military service. Conclusion: Tinea pedis is highly prevalent in Israeli soldiers. Association of tinea pedis with the setting of military training suggests that contagious spread may be an important risk factor. We suggest that environmental interventions should be planned to in order to decrease the morbidity of tinea pedis among soldiers. 展开更多
关键词 危险因素 患病率 以色列 足癣 士兵 FISHER 存在情况 检验分析 横断面调查 显微镜检查
下载PDF
不同种族人群高血压患者的靶器官损害
3
作者 wolak T. anfanger S. +1 位作者 wolak a. 刘少伟 《世界核心医学期刊文摘(心脏病学分册)》 2007年第7期53-53,共1页
背景:高血压在不同种族的人群中可伴随不同的靶器官损害。以色列人口的多样性为评估不同种族人群高血压患者的靶器官损害提供了机会。方法和结果:从初级医疗诊所中收集高血压患者的计算机化医疗档案。对576例高血压患者进行分析:138... 背景:高血压在不同种族的人群中可伴随不同的靶器官损害。以色列人口的多样性为评估不同种族人群高血压患者的靶器官损害提供了机会。方法和结果:从初级医疗诊所中收集高血压患者的计算机化医疗档案。对576例高血压患者进行分析:138例贝多因人(阿拉伯居民)、141例瑟法底犹太人(北非和中东移民)、152例亚裔-印度犹太人(印度移民)和145例阿肯纳西犹太人(欧洲、北美洲和南美洲移民)。在对已知的危险因素和种族校正后的多元Logistic回归分析中,亚裔-印度犹太人的脑血管疾病患病率最高(OR3.09,P=0.009)。 展开更多
关键词 高血压患者 靶器官损害 种族人群 多元LOGISTIC回归分析 犹太人 医疗档案 计算机化 医疗诊所
下载PDF
急性冠脉综合征冠脉介入治疗期间依诺肝素能够安全替代普通肝素吗?
4
作者 wolak a. ayzenberg Y. +2 位作者 Cafri C. D. Zahger 王亭忠 《世界核心医学期刊文摘(心脏病学分册)》 2005年第1期34-35,共2页
Background: Enoxaparin has gained wide acceptance in patients with acut e coron ary syndromes. However, there is uncertainty regarding management of patients wh o require coronary intervention while on enoxaparin. Som... Background: Enoxaparin has gained wide acceptance in patients with acut e coron ary syndromes. However, there is uncertainty regarding management of patients wh o require coronary intervention while on enoxaparin. Some physicians withhold th e morning dose of enoxaparin prior to coronary intervention while others switch patients to unfractionated heparin. Both methods do not provide optimal anticoag ulation in the hours preceding intervention. There are no published controlled data to assess the safety of coronary intervention using enoxaparin alone in patients with acute coronary syndromes. Methods: We p rospectively compared enoxaparin to unfractionated heparin during coronary angio graphy and intervention. Sixty four patients admitted to the coronary care unit( CCU)were given enoxaparin twice daily, including on the morning of procedure. Co ronary angiography and intervention were performed without additional unfraction ated heparin. The control group comprised of 52 patients admitted to Internal Me dicine for an acute coronary syndrome. These were also given enoxaparin but the morning dose was withheld and unfractionated heparin was used during procedure. Results: Patients in both groups had similar baseline characteristics. No signif icant differences were observed between the two groups in procedural success rat e, complications or bleeding. One year follow up showed similar rates of hospita lization and mortality. Conclusion: Enoxaparin seems to offer safe and effective procedural anticoagulation in patients undergoing percutaneous intervention for acute coronary syndromes. Patients given enoxaparin can probably have coronary intervention without interruption of enoxaparin treatment and without additional procedural anticoagulation. These findings require confirmation in larger, rand omized trials. 展开更多
关键词 依诺肝素 急性冠脉综合征 普通肝素 冠脉介入治疗 冠脉造影 抗凝作用 住院率 随机试验
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部